GKTFDA Class 2 · 21 CFR 864.9245

Separator, Automated, Blood Cell, Diagnostic

Device family · Hematology

Automated profile from regulatory + adverse-event registries · AI-reviewed · expert clinical sign-off in progress — not yet independently verified.
FDA clearances
10
Manufacturers
2
Flagged signals
13
Adverse-event reports
5,528

Code matrix

FDA product codeGKT
Device classClass 2
Regulation21 CFR 864.9245
GMDN— (crosswalk pending)
ImplantableNo
Life-sustainingNo

Adverse-event signals

Public · always free

MAUDE disproportionality (PRR), flagged where PRR ≥ 2, χ² ≥ 4, count ≥ 3.

Event typeYearReportsPRRχ²
Other2011640.3193
Other2011426.976
Other2012426.976
Other2010320.237
2012618.281
Death2021204.552
Death202534.35
Death2020184.139
Death2019184.139
Death2022163.628
Death2024163.628
Death2023122.712
Death2018102.36

Device-level recall linkage pending an FDA-recalls product-code re-ingest. Class 2 family · 5,528 total adverse-event reports.

Manufacturer landscape

ManufacturerClearancesLatestConcern
Travenol Laboratories, S.A.21980
Fresenius Kabi AG12020

Concern score lights up where a maker maps to a scored entity (depth fast-follow).

Recent FDA clearances

AMICUS Separator System · Fresenius Kabi AG510(k) · 2020-09-11
AMICUS Separator System, AMICUS Separator System; Refurbished · Fresenius Kabi USA,Llc510(k) · 2016-11-23
AUTOMATED BLOOD CELL SEPARATOR · Cryosan, Inc.510(k) · 1982-09-30
AUTOMATED BLOOD CELL SEPAR. DISP. SFTWR · Pheragen Technology Corp.510(k) · 1982-04-27
CELLTRIFUGE II · Travenol Laboratories, S.A.510(k) · 1980-10-31
STERILE, DISPOSABLE CENTRIFUGE BOWL · Travenol Laboratories, S.A.510(k) · 1979-08-10
TERUMO IMUGARD · Terumo America, Inc.510(k) · 1979-05-24
FILTER, EYRPUR DISPOSABLE LEUKOCITE · Metrix Teknika, Inc.510(k) · 1979-01-17
BLOOD CELL SEPARATOR 2997 · Intl. Business Machines510(k) · 1977-09-06
BLOOD CELL PROCESSOR MODEL 2 IBM 2991 · Intl. Business Machines510(k) · 1977-01-10

Sources: FDA 510(k)/PMA · openFDA MAUDE · FDA device classification · MedevIQ manufacturer-canonical. Registry data, AI-reviewed; expert clinical sign-off in progress.

Early access

MedevIQ is in private preview.

We're onboarding hospitals, manufacturers, regulators and research teams in waves. Tell us how you'd use MedevIQ and we'll get back within a working week.

We'll reply within a working week.

Access by invitation while v1 finalizes.